Fredrik Kahn

1.3k total citations
58 papers, 780 citations indexed

About

Fredrik Kahn is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Fredrik Kahn has authored 58 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 18 papers in Public Health, Environmental and Occupational Health and 15 papers in Epidemiology. Recurrent topics in Fredrik Kahn's work include Streptococcal Infections and Treatments (14 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Autoimmune and Inflammatory Disorders Research (8 papers). Fredrik Kahn is often cited by papers focused on Streptococcal Infections and Treatments (14 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Autoimmune and Inflammatory Disorders Research (8 papers). Fredrik Kahn collaborates with scholars based in Sweden, Switzerland and Canada. Fredrik Kahn's co-authors include Magnus Rasmussen, Adam Linder, Oonagh Shannon, Robin Kahn, Anders Bengtsson, Bértil Christensson, Lisa Mellhammar, Per Åkesson, Sinéad Hurley and Jonas Björk and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Gastroenterology.

In The Last Decade

Fredrik Kahn

53 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fredrik Kahn Sweden 17 264 229 173 158 123 58 780
Volker Strenger Austria 19 386 1.5× 334 1.5× 81 0.5× 79 0.5× 57 0.5× 57 859
Vincent Bekker Netherlands 20 495 1.9× 245 1.1× 367 2.1× 131 0.8× 49 0.4× 58 1.1k
Enrico Schalk Germany 18 333 1.3× 251 1.1× 57 0.3× 50 0.3× 135 1.1× 57 1.0k
Evangelia Farmaki Greece 19 363 1.4× 430 1.9× 122 0.7× 176 1.1× 105 0.9× 65 1.1k
Shannon Novosad United States 15 569 2.2× 430 1.9× 89 0.5× 100 0.6× 66 0.5× 36 1.2k
Marissa M. Alejandria Philippines 10 315 1.2× 195 0.9× 162 0.9× 95 0.6× 47 0.4× 36 706
Samuel Wilson United States 17 279 1.1× 246 1.1× 199 1.2× 102 0.6× 52 0.4× 51 686
Jasjit Singh United States 17 290 1.1× 169 0.7× 118 0.7× 32 0.2× 83 0.7× 78 730
Elina Kolho Finland 17 930 3.5× 282 1.2× 173 1.0× 71 0.4× 113 0.9× 38 1.4k
Lars Heggelund Norway 23 556 2.1× 237 1.0× 39 0.2× 340 2.2× 137 1.1× 49 1.2k

Countries citing papers authored by Fredrik Kahn

Since Specialization
Citations

This map shows the geographic impact of Fredrik Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fredrik Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fredrik Kahn more than expected).

Fields of papers citing papers by Fredrik Kahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fredrik Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fredrik Kahn. The network helps show where Fredrik Kahn may publish in the future.

Co-authorship network of co-authors of Fredrik Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Fredrik Kahn. A scholar is included among the top collaborators of Fredrik Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fredrik Kahn. Fredrik Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rasmussen, Magnus, Ariane Neumann, Mahnaz Moghaddassi, et al.. (2025). Anti-SARS-CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 vaccination. Infectious Diseases. 57(8). 782–792. 1 indexed citations
2.
Hedberg, Pontus, Fredrik Kahn, Åsa Nilsdotter‐Augustinsson, et al.. (2025). Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: focus on the very early period and Omicron era. Blood Advances. 9(13). 3170–3181. 1 indexed citations
5.
Kahn, Fredrik, Åsa Nilsdotter‐Augustinsson, Mats Fredrikson, et al.. (2024). Inborn errors of immunity are associated with increased COVID-19–related hospitalization and intensive care compared to the general population. Journal of Allergy and Clinical Immunology. 155(2). 387–397.e6. 2 indexed citations
7.
Kahn, Fredrik, et al.. (2024). NETQUANT2: automated web-based quantification of neutrophil extracellular traps from fluorescence microscopy. Frontiers in Immunology. 15. 1459933–1459933.
8.
Arve-Butler, Sabine, et al.. (2023). Identification of novel autoantigens as potential biomarkers in juvenile idiopathic arthritis associated uveitis. Frontiers in Pediatrics. 10. 1091308–1091308. 3 indexed citations
9.
Król, Petra, Sabine Arve-Butler, Anders Bengtsson, et al.. (2023). Synovial monocytes contribute to chronic inflammation in childhood-onset arthritis via IL-6/STAT signalling and cell-cell interactions. Frontiers in Immunology. 14. 1190018–1190018. 6 indexed citations
10.
Kahn, Fredrik, et al.. (2022). Treatment outcome with penicillin G or cloxacillin in penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective cohort study. International Journal of Antimicrobial Agents. 59(4). 106567–106567. 7 indexed citations
12.
Fisher, Jane, Fredrik Kahn, Thomas Kander, et al.. (2021). The Dynamics of Circulating Heparin-Binding Protein: Implications for Its Use as a Biomarker. Journal of Innate Immunity. 14(5). 447–460. 10 indexed citations
13.
Krus, David J., Fredrik Kahn, Bo Nilson, Torgny Sunnerhagen, & Magnus Rasmussen. (2021). Blood culture time to positivity in non-β-hemolytic streptococcal bacteremia as a predictor of infective endocarditis—a retrospective cohort study. European Journal of Clinical Microbiology & Infectious Diseases. 41(2). 325–329. 10 indexed citations
14.
Björk, Jonas, Karin Modig, Fredrik Kahn, & Anders Ahlbom. (2021). Revival of ecological studies during the COVID-19 pandemic. European Journal of Epidemiology. 36(12). 1225–1229. 10 indexed citations
15.
Kahn, Fredrik, et al.. (2020). Time to blood culture positivity in Staphylococcus aureus bacteraemia to determine risk of infective endocarditis. Clinical Microbiology and Infection. 27(9). 1345.e7–1345.e12. 43 indexed citations
16.
Inghammar, Malin, Lisa I. Påhlman, John H. Boyd, et al.. (2020). Risk of bacteremia in patients presenting with shaking chills and vomiting - a prospective cohort study. Epidemiology and Infection. 148. e86–e86. 4 indexed citations
17.
Nielsen, Niklas, et al.. (2020). Repeated measures of Heparin-binding protein (HBP) and procalcitonin during septic shock: biomarker kinetics and association with cardiovascular organ dysfunction. Intensive Care Medicine Experimental. 8(1). 51–51. 16 indexed citations
18.
Kahn, Fredrik, et al.. (2018). Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis. BMC Pulmonary Medicine. 18(1). 104–104. 14 indexed citations
19.
Hurley, Sinéad, Fredrik Kahn, Pontus Nordenfelt, et al.. (2015). Platelet-Dependent Neutrophil Function Is Dysregulated by M Protein from Streptococcus pyogenes. Infection and Immunity. 83(9). 3515–3525. 25 indexed citations
20.
Wu, Yongzheng, et al.. (2013). Secreted Group IIA Phospholipase A2 Protects Humans Against the Group B Streptococcus: Experimental and Clinical Evidence. The Journal of Infectious Diseases. 208(12). 2025–2035. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026